Literature DB >> 11741312

The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1,25(OH)(2)D(3).

C Buitrago1, G Vazquez, A R De Boland, R Boland.   

Abstract

It has been recently shown that the fast non-genomic responses of 1,25(OH)(2)-vitamin D(3) [1,25(OH)(2)D(3)] in skeletal muscle cells involve tyrosine phosphorylation of MAP kinase (ERK1/2), c-Src kinase and the oncoprotein c-myc. In the present work, blockade of vitamin D receptor (VDR) expression (> or =80%) by preincubation of chick embryonic muscle cells with three different antisense oligonucleotides against the VDR mRNA (AS-VDR ODNs) significantly reduced (-94%) 1,25(OH)(2)D(3) stimulation of c-myc tyrosine phosphorylation and inhibited c-Src tyrosine dephosphorylation implying lack of c-Src activation by the hormone. Coimmunoprecipitation experiments revealed that 1,25(OH)(2)D(3) induces the formation of complexes between c-Src and c-myc, in agreement with the above results and previous studies showing hormone-dependent association between c-Src and tyrosine phosphorylated VDR and c-Src mediated c-myc tyrosine phosphorylation. MAPK tyrosine phosphorylation by 1,25(OH)(2)D(3) was affected to a lesser extent (-35%) by transfection with AS-VDR ODNs implying that both VDR-dependent and VDR-independent signalling mediate hormone stimulation of MAPK. These are the first results providing direct evidence on the participation of the VDR in non-genomic 1,25(OH)(2)D(3) signal transduction. Activation of tyrosine phosphorylation cascades through this mechanism may contribute to hormone regulation of muscle growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11741312     DOI: 10.1006/bbrc.2001.6072

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Genetic influences in sport and physical performance.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-10-01       Impact factor: 11.136

2.  Effect of Absent Immune Cell Expression of Vitamin D Receptor on Cardiac Allograft Survival in Mice.

Authors:  Samuel J Gavzy; Peter S Heeger
Journal:  Transplantation       Date:  2015-07       Impact factor: 4.939

3.  The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations.

Authors:  Edgar Turner Overton; Michael T Yin
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

Review 4.  Proteins of multiple classes may participate in nongenomic steroid actions.

Authors:  Cheryl S Watson; Bahiru Gametchu
Journal:  Exp Biol Med (Maywood)       Date:  2003-12

5.  Activation of rapid signaling pathways does not contribute to 1 alpha,25-dihydroxyvitamin D3-induced growth inhibition of mouse prostate epithelial progenitor cells.

Authors:  Jia Li; James C Fleet; Dorothy Teegarden
Journal:  J Cell Biochem       Date:  2009-08-01       Impact factor: 4.429

6.  Chaperone properties of pdia3 participate in rapid membrane actions of 1α,25-dihydroxyvitamin d3.

Authors:  Jiaxuan Chen; Kirill S Lobachev; Brian J Grindel; Mary C Farach-Carson; Sharon L Hyzy; Khairat B El-Baradie; Rene Olivares-Navarrete; Maryam Doroudi; Barbara D Boyan; Zvi Schwartz
Journal:  Mol Endocrinol       Date:  2013-05-09

7.  The role of vitamin D in skeletal and cardiac muscle function.

Authors:  Patsie Polly; Timothy C Tan
Journal:  Front Physiol       Date:  2014-04-16       Impact factor: 4.566

8.  1,25-Dihydroxyvitamin D3 increases testosterone-induced 17beta-estradiol secretion and reverses testosterone-reduced connexin 43 in rat granulosa cells.

Authors:  Ching-Tien Lee; Jiz-Yuh Wang; Kuang-Yi Chou; Ming-I Hsu
Journal:  Reprod Biol Endocrinol       Date:  2014-09-20       Impact factor: 5.211

Review 9.  Vitamin D signaling in myogenesis: potential for treatment of sarcopenia.

Authors:  Akira Wagatsuma; Kunihiro Sakuma
Journal:  Biomed Res Int       Date:  2014-06-30       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.